291650 — Aptamer Sciences Share Price
0.000.00%
Last trade - 00:00- KR₩31bn
- KR₩16bn
- KR₩1bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.24 | ||
| Price to Tang. Book | 1.34 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 28.61 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -24.46% | ||
| Return on Equity | -43.52% | ||
| Operating Margin | -634.37% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 228.51 | 269.28 | 358.25 | 243.19 | 1,082.81 | n/a | n/a | 21.58% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aptamer Sciences Inc is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The Company provides services include aptamer synthesis and aptamer discovery. The Company also develops biopharmaceuticals such as insulin substitutes, insulin sensitizers, and liver cancer drugs. In addition, the Company also produces lung cancer diagnostic kits.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 1st, 2011
- Public Since
- September 16th, 2020
- No. of Shareholders
- 14,366
- No. of Employees
- 55
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 29,280,252
- Address
- 301, 3 Dong, Pangyo Seven Venture Valy 1, SEONGNAM, 13487
- Web
- http://aptsci.com/
- Phone
- +82 317860317
- Auditors
- Daejoo Accounting Corp.
Upcoming Events for 291650
Q2 2025 Aptamer Sciences Inc Earnings Release
Similar to 291650
3Billion
Korea Exchange - KOSDAQ
ABion
Korea Exchange - KOSDAQ
ABL Bio
Korea Exchange - KOSDAQ
Amicogen
Korea Exchange - KOSDAQ
AprilBio Co
Korea Exchange - KOSDAQ
FAQ
What is the Aptamer Sciences share price?
As of Today at 19:18 UTC, shares in Aptamer Sciences are trading at KR₩1,058. This share price information is delayed by 15 minutes.
How has the Aptamer Sciences share price performed this year?
Shares in Aptamer Sciences last closed at KR₩1,058 and the price had moved by -53.24% over the past 365 days. In terms of relative price strength the Aptamer Sciences share price has underperformed the FTSE Developed Asia Pacific Index by -52.7% over the past year.
What are the analyst and broker recommendations for Aptamer Sciences?
There is no consensus recommendation for this security.
Find out moreWhat is the Aptamer Sciences dividend yield?
Aptamer Sciences does not currently pay a dividend.
Does Aptamer Sciences pay a dividend?
Aptamer Sciences does not currently pay a dividend.
When does Aptamer Sciences next pay dividends?
Aptamer Sciences does not currently pay a dividend.
How do I buy Aptamer Sciences shares?
To buy shares in Aptamer Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Aptamer Sciences?
As of the previous close price of KR₩1,058, shares in Aptamer Sciences had a market capitalisation of KR₩31bn.
Where are Aptamer Sciences shares listed?
Here are the trading details for Aptamer Sciences:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 291650
What kind of share is Aptamer Sciences?
Based on an overall assessment of its quality, value and momentum Aptamer Sciences is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Aptamer Sciences share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Aptamer Sciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aptamer Sciences. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -47.7%.
As of the last closing price of KR₩1,058, shares in Aptamer Sciences were trading -36.72% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Aptamer Sciences PE Ratio?
The Aptamer Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩1,058.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Aptamer Sciences?
We do not have data on Aptamer Sciences' directors